Skip to content

Refractory Focal Epilepsy

NO LONGER ACCEPTING APPLICATIONS
Published on:
September 18, 2024
Sign-up Expiration:
Updated:
Topics:
Locations:

A Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of BHV-7000 in Subjects with Refractory Focal Epilepsy.

View Additional Information
View Clinical Trial Attachment
Sign Up NowExpired - View Other Trials
ENDED